Additionally, the epidermal growth factor receptor (EGFR), which belongs to the ErbB family of receptor tyrosine kinases, is overexpressed in various human cancers, becoming a target for cancer therapies even used in clinical treatment (Sigismund et al., 2018). This evidence concerns the gene NTRK1 and cancer.